Elutia (NASDAQ:ELUT) Trading Up 1.7%

Elutia Inc. (NASDAQ:ELUTGet Free Report)’s stock price rose 1.7% on Thursday . The stock traded as high as $3.40 and last traded at $3.40. Approximately 2,843 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 20,285 shares. The stock had previously closed at $3.34.

Analysts Set New Price Targets

Separately, Cantor Fitzgerald cut their price objective on shares of Elutia from $6.00 to $5.00 and set an “overweight” rating for the company in a report on Friday, May 10th.

Read Our Latest Report on Elutia

Elutia Trading Up 1.7 %

The stock has a market capitalization of $82.52 million, a PE ratio of -1.43 and a beta of 0.61. The firm’s fifty day moving average is $3.09 and its 200-day moving average is $3.02.

Elutia (NASDAQ:ELUTGet Free Report) last released its earnings results on Thursday, May 9th. The company reported ($0.75) EPS for the quarter. The company had revenue of $6.69 million during the quarter. As a group, equities analysts predict that Elutia Inc. will post -1.38 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Elutia stock. Verdence Capital Advisors LLC bought a new stake in Elutia Inc. (NASDAQ:ELUTFree Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 14,410 shares of the company’s stock, valued at approximately $45,000. Verdence Capital Advisors LLC owned approximately 0.06% of Elutia as of its most recent SEC filing. Institutional investors and hedge funds own 74.03% of the company’s stock.

Elutia Company Profile

(Get Free Report)

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.

Featured Stories

Receive News & Ratings for Elutia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elutia and related companies with MarketBeat.com's FREE daily email newsletter.